Cardiovascular aspects of growth hormone replacement therapy in adults

Endocrinology and Metabolism, Supplement

Volumn 3, Issue SUPPL. A, 1996, Pages 19-22

  Christiansen, Jens S ^a,b   Jørgensen, Jens O L ^a,b   Thuesen, Leif ^a,b  

^a Departments of Endocrinology

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; PLACEBO;

ADULT; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; DOUBLE BLIND PROCEDURE; GROWTH HORMONE DEFICIENCY; HEART INDEX; HEART MUSCLE CONTRACTILITY; HEART RATE; HORMONE SUBSTITUTION; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; SYSTOLIC BLOOD PRESSURE;

EID: 0029522071     PISSN: 1074939X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Rosen T, Bengtsson B-Å. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990; 336: 285-288.
2. Markussis V, Beshyah SA, Fisher C, Sharp P, Nicolaides AN, Johnston DG. Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet 1992; 340: 1188-1192.
3. Penny DG, Dunbar JC, Baylerian MS. Cardiomegaly and haemodynamics in rats with a transplantable growth hormone secreting tumour. Cardiovasc. Res. 1985; 19: 270-277.
4. Thuesen L, Christiansen JS, Sørensen KE, Jørgensen JOL, Ørskov H, Henningsen P. Increased myocardial contractility following growth hormone administration in normal man. Dan. Med. Bull. 1988; 35: 193-196.
5. Cuneo RC, Wilmshurst P, Lowy C, McGauley G, Sönksen PH. Cardiac failure responding to growth hormone. Lancet 1989; i: 838-839.
6. Jørgensen JOL, Pedersen SA, Thuesen L, Jørgensen J, Ingemann-Hansen T, Skakkebaek NE, Christiansen JS. Beneficial effects of growth hormone treatment in GH-deficient adults on body composition, muscle strength, exercise capacity and cardiac and renal function. Lancet 1989; i: 1221-1225.
7. Cuneo RC, Salomon F, Wilmhurst P, Byrne C, Wiles CM, Hesp R, Sönksen PH. Cardiovascular effects of growth hormone treatment in growth hormone deficient adults: stimulation of the renin-angiotensinaldosterone system. Clin. Sci. 1991; 81: 587-592.
8. Amato G, Carella C, Fazio S, La Montagna G, Cittadini A, Sabatini D, Marciano-Mone C, Saccâ L, Bellastella A. Body composition, bone metabolism and heart structure and function in growth hormone (GH) deficient adults before and after GH replacement therapy at low doses. J. Clin. Endocrin. Metab. 1993; 77: 1671-1676.
9. Jørgensen JOL, Pedersen SA, Thuesen L, Jørgensen J, M0ller J, Müller J, Skakkebaek NE, Christiansen JS. Long-term growth hormone treatment in growth hormone deficient adults. Acta Endocrinol. 1991; 125: 449-453.
10. Thuesen L, Jørgensen JOL, Müller JR, Kristensen B0, Skakkebaek NE, Vahl N, Christiansen JS. Short and long-term cardiovascular effects of growth hormone therapy in growth hormone deficient adults. Clin. Endocrinol. 1994; 41: 615-620.
11. Jørgensen KD. Comparison of the pharmacological properties of pituitary and biosynthetic human growth hormone. Demonstration of antinatriuretic/ antidiuretic and barbital sleep effects of human growth hormone in rats. Acta Endocrinol. 1987; 114: 124-131.
12. Thuesen L, Christiansen JS, Sørensen KE, Ørskov H, Henningsen P. Increased myocardial contractility following growth hormone administration in normal man. An echocardiographic study. Dan. Med. Bull. 1988; 35: 193-196.
13. Wright AD, Hill DM, Lowy C, Franzer TR. Mortality in acromegaly. Q. J. Med. 1970; 39: 1-16.